<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03897023</url>
  </required_header>
  <id_info>
    <org_study_id>GMPS1</org_study_id>
    <nct_id>NCT03897023</nct_id>
  </id_info>
  <brief_title>Gut Microbiota Pilot Study</brief_title>
  <official_title>Anaylsis of Gut Microbiota in ICU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Catholic University of Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Catholic University of Korea</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Microbiota is known to effect metabolism. This is pilot study to get status of microbiota
      from normal control. It will be compared to data from specific patients in ICU via further
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Microbiota is known to effect metabolism. This is pilot study to get status of microbiota
      from normal control. It will be compared to data from specific patients in ICU via further
      study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 15, 2019</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stuatus of gut microbiota in stable patient</measure>
    <time_frame>1 Month</time_frame>
    <description>Result of next generation sequencing</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Microbiota</condition>
  <condition>Metabolism</condition>
  <arm_group>
    <arm_group_label>Stable patient</arm_group_label>
    <description>Stable patients who admitted to ICU for observation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Gut Microbiota</intervention_name>
    <description>Status of microbiota</description>
    <arm_group_label>Stable patient</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Stool
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Stable adult patient who are admitted to ICU
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Older than 17 years old

          -  Every patients who are admitted to ICU

        Exclusion Criteria:

          -  With history of disease such as cancer, Crohn's disease, ulcerative colitis, irritable
             bowel syndrome

          -  With history of immunosuppressive agents.

          -  Initial systolic blood pressure &lt;100

          -  Initial pulse rate &gt; 100

          -  Need emergent operation at brain or torso

          -  Need vasopressor, transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maru Kim, MD., Ph.D.</last_name>
    <phone>82318205266</phone>
    <email>maru@catholic.ac.kr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uijeongbu St.Mary's hospital</name>
      <address>
        <city>Uijeongbu-si</city>
        <state>Gyeonggi-do</state>
        <zip>11765</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maru Kim</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>March 28, 2019</study_first_submitted>
  <study_first_submitted_qc>March 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>July 26, 2019</last_update_submitted>
  <last_update_submitted_qc>July 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Catholic University of Korea</investigator_affiliation>
    <investigator_full_name>Maru Kim</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

